Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Pembrolizumab-induced dual endocrine disruption: A case report
María Carmen Dameto Pons; Elena González Arnáiz; María Antequera González; Xavier F. Pérez Candel; Diana Ariadel Cobo; Javier Castañón Alonso; María D. Ballesteros Pomar;
Endocrinol Diabetes Nutr. 2025;72:
Regulation of the cellular redox state and the expression of DNA methyltransferase-1 in peripheral blood mononuclear cells from patients with Graves¿ disease
Melina Saban; Melisa Costilla; Alicia Juana Klecha; Mariana Di Cugno; Marina Inés Curria; Graciela Cremaschi; María Laura Barreiro Arcos;
Endocrinol Diabetes Nutr. 2022;69:409-17
Follow-up of infants born to mothers with Graves¿ disease
Cristiana Maximiano; Marta Ribeiro Silva; Fábia Carvalho; Juliana Almeida; Maria Miguel Gomes; Sofia Martins; Olinda Marques; Alexandra Estrada; Almerinda Pereira; Ana Antunes;
Endocrinol Diabetes Nutr. 2021;68:472-80